SAN FRANCISCO, Jan 13 (Reuters) - AstraZeneca has agreed to buy Boston-based Modella AI, the companies said on Tuesday, as the drug industry increases its use of artificial intelligence to accelerate the discovery of new drugs.
The companies did not disclose financial terms. In a press release, Modella AI said its "foundation models" and AI agents would be integrated into oncology research and development to support clinical development and biomarker discovery.
"Oncology drug development is becoming more complex, more data-rich and more time-sensitive," said Gabi Raia, Modella AI's chief commercial officer, adding that joining AstraZeneca would allow it to deploy its tools in global trials and clinical settings.
AstraZeneca said that this was the first acquisition of an AI firm by a big pharmaceutical company.
In an interview at the JP Morgan Healthcare Conference, AstraZeneca Chief Financial Officer Aradhana Sarin said the acquisition would "supercharge" the company's quantitative pathology and biomarker discovery efforts by bringing more data and AI capabilities in-house.
The deal was one of a number of pacts between major drug firms and AI companies that were unveiled at the healthcare conference, including a $1 billion collaboration between Nvidia and Eli Lilly. They plan to build a new research lab using Nvidia's latest-generation AI chips.
Modella will accelerate AstraZeneca’s efforts to make pathology more quantitative - using computers to analyze biopsies for relevant proteins and correlate them with clinical data - so AstraZeneca can develop “highly targeted biomarkers and then highly targeted therapeutics,” Sarin said.
The deal is an expansion of a multi-year collaboration that the companies unveiled in July.
Sarin said that partnership served as a "test drive," adding that AstraZeneca ultimately wanted Modella's data, foundation models and AI talent in-house.
She said AI tools could be used to more rapidly select patients for drug trials, which could increase the odds of clinical success and cut related costs.
(Reporting by Maggie Fick; Editing by Thomas Derpinghaus)
latest_posts
- 1
UN torture cm'tee report flags Israel for allegedly mistreating journalists, detainees, ex-MAG - 25 State of the art Advancements in Computer generated Simulation
- 3FDA adds strongest warning to Sarepta gene therapy linked to 2 patient deaths
- 4How Mars' ancient lakes grew shields of ice to stay warm as the Red Planet froze
- 5NASA's Artemis 2 pilot Victor Glover listens to 'Whitey on the Moon' every Monday. This is why.
- the 6 Shrewd Beds for seniors: A Complete Survey
- WHO suspends medical evacuations from Gaza following death of contractor in 'security incident'
- Which European countries have mandatory or voluntary military service
- Tech Development Disclosed: A Survey of \Usefulness and Configuration in Concentration\ Tech Item
- The German series proving subtitles can be sexy — and wildly addictive
- The most effective method to Go with Informed Choices on Vehicle Leases
- The moon up close: How the Artemis 2 astronauts are photographing their historic lunar flyby
- Did Japan’s PM Actually Back the Memecoin Bearing Her Name?
- Landslides triggered by heavy rainfall kill at least 20 people in Tanzania
